- Home
- BRTX vs JTAI Comparison
BRTX vs JTAI Comparison
Compare BRTX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- JTAI
- Stock Information
- Founded
- BRTX 1997
- JTAI 2018
- Country
- BRTX United States
- JTAI United States
- Employees
- BRTX 11
- JTAI N/A
- Industry
- BRTX Managed Health Care
- JTAI Blank Checks
- Sector
- BRTX Health Care
- JTAI Finance
- Exchange
- BRTX Nasdaq
- JTAI Nasdaq
- Market Cap
- BRTX 13.7M
- JTAI 9.9M
- IPO Year
- BRTX N/A
- JTAI N/A
- Fundamental
- Price
- BRTX $1.67
- JTAI $4.41
- Analyst Decision
- BRTX Strong Buy
- JTAI
- Analyst Count
- BRTX 1
- JTAI 0
- Target Price
- BRTX $18.00
- JTAI N/A
- AVG Volume (30 Days)
- BRTX 27.4K
- JTAI 409.1K
- Earning Date
- BRTX 05-14-2025
- JTAI 05-19-2025
- Dividend Yield
- BRTX N/A
- JTAI N/A
- EPS Growth
- BRTX N/A
- JTAI N/A
- EPS
- BRTX N/A
- JTAI N/A
- Revenue
- BRTX $401,000.00
- JTAI $14,022,628.00
- Revenue This Year
- BRTX $446.88
- JTAI $16.48
- Revenue Next Year
- BRTX $39.53
- JTAI $193.11
- P/E Ratio
- BRTX N/A
- JTAI N/A
- Revenue Growth
- BRTX 175.03
- JTAI 14.80
- 52 Week Low
- BRTX $1.03
- JTAI $2.30
- 52 Week High
- BRTX $2.55
- JTAI $175.50
- Technical
- Relative Strength Index (RSI)
- BRTX 41.86
- JTAI 53.80
- Support Level
- BRTX $1.66
- JTAI $4.17
- Resistance Level
- BRTX $1.88
- JTAI $4.59
- Average True Range (ATR)
- BRTX 0.08
- JTAI 0.29
- MACD
- BRTX -0.01
- JTAI 0.06
- Stochastic Oscillator
- BRTX 8.33
- JTAI 69.79
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.